| Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 |
Globe Newswire |
09/23 |
08:00 |
| Vortex Energy Retrieves 279 Meters Of Core Containing Visible Salt Mineralization From The Robinsons River Salt Project |
Globe Newswire |
09/23 |
08:00 |
| Hearing Aid Market to Witness 6.30% CAGR by 2031 | SkyQuest Technology |
Globe Newswire |
09/23 |
08:00 |
| Xunlei Announces Appointment of Two New Directors |
Globe Newswire |
09/23 |
08:00 |
| Applied Digital Sets Fiscal First Quarter 2025 Earnings Conference Call for Wednesday, October 9, 2024 at 5:00 p.m. Eastern Time |
Globe Newswire |
09/23 |
08:00 |
| The Oncology Institute Announces CFO Transition |
Globe Newswire |
09/23 |
08:00 |
| Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi |
Globe Newswire |
09/23 |
08:00 |
| Provident Bank Welcomes Vivin Varghese As Senior Vice President, Chief Information Security Officer |
Globe Newswire |
09/23 |
08:00 |
| ARS Pharmaceuticals Announces U.S. Availability of neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis |
Globe Newswire |
09/23 |
08:00 |
| LifeSci Advisors Appoints Lindsey Trickett to its Investor Relations Team |
Globe Newswire |
09/23 |
08:00 |
| Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310 Leading Overall Survival Analysis |
Globe Newswire |
09/23 |
08:00 |
| Integer Completes Two Irish Facility Expansions to Support Growth, Strengthen Capabilities in Critical Medtech Region |
Globe Newswire |
09/23 |
08:00 |
| Kratos SRE Welcomes Congressman Gary Palmer to Facility in Birmingham |
Globe Newswire |
09/23 |
08:00 |
| Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT7439 (CDK12/13 Inhibitor) |
Globe Newswire |
09/23 |
08:00 |
| Crypto Proprietary Trading Firm HyroTrader Experiences Rapid Growth |
Globe Newswire |
09/23 |
07:59 |
| ProStar Announces that a Global Fortune 500 Energy Company Adopts PointMan to Improve Refinery Maintenance Operations |
Globe Newswire |
09/23 |
07:58 |
| Three Protocol Introduces Fraud-Resistant eCommerce Solutions, Pioneering Crypto as the Future of Payment |
Globe Newswire |
09/23 |
07:56 |
| Sports.com Expands Geographical Footprint, Launching in New Markets Across Asia |
Globe Newswire |
09/23 |
07:53 |
| Luzhou Hosted The 3rd Global Geographical Indications Products Expo |
Globe Newswire |
09/23 |
07:52 |
| Brookfield Global Infrastructure Securities Income Fund Announces Quarterly Distribution |
Globe Newswire |
09/23 |
07:50 |
| Jeffs’ Brands: Fort Products Recognized by Amazon UK as a Key Account, Eligible for the Top Seller Program |
Globe Newswire |
09/23 |
07:45 |
| Lydia Ko pulls away with a 63 to win Queen City Championship in Ohio for 3rd LPGA title of the year |
AP Online |
09/23 |
07:35 |
| Discover the TTcoin (TC) Listing on XT |
Globe Newswire |
09/23 |
07:33 |
| FTI Consulting Adds EY Global M&A Leader to Transactions Practice |
Globe Newswire |
09/23 |
07:30 |
| BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody |
Globe Newswire |
09/23 |
07:30 |
